Egypt retains global lead in frozen strawberry exports in '24    Egypt allocates EGP5bn to support MSMEs, entrepreneurs    EGP starts week flat against the US dollar    Egypt, Mexico explore joint action on environment, sustainability    New expansion projects, public-private partnerships to modernize, localise industry: El-Shimy    Al-Sisi attends high-level African summit to strengthen continental coordination, regional integration    Al-Wazir inaugurates glass factory, lays foundation stone for new appliance plant at Elaraby Group    Egypt, Mexico discuss environmental cooperation, combating desertification    Egypt launches anti-drug awareness campaign for drivers    HDB expands national footprint with 'Acacia' branch in New Cairo    Lavrov warns against anti-Russia alliances in Asia during North Korea visit    Germany faces recruitment hurdles in push to rearm, eyes conscription    Needle-spiking attacks in France prompt government warning, public fear    Foreign, housing ministers discuss Egypt's role in African development push    Egypt's EDA, Haleon discuss local market support    Korea Culture Week in Egypt to blend K-Pop with traditional arts    Egypt, France FMs review Gaza ceasefire efforts, reconstruction    CIB finances Giza Pyramids Sound and Light Show redevelopment with EGP 963m loan    Greco-Roman tombs with hieroglyphic inscriptions discovered in Aswan    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Egypt condemns deadly terrorist attack in Niger        Sisi launches new support initiative for families of war, terrorism victims    Egypt's GAH, Spain's Konecta discuss digital health partnership    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Huge potential for pharmaceuticals
Published in Ahram Online on 20 - 04 - 2021

Sales of Egyptian pharmaceuticals rose by 11 per cent in 2019, and on a global scale the pharmaceuticals sector grew by three per cent in 2020 aided by the Covid-19 pandemic, even if most pharmaceuticals markets saw a retreat in sales, said Ahmed Al-Ezaby, chair of the Pharmaceuticals Chamber at the Federation of Egyptian Industries.
Al-Ezaby was speaking about Egypt's being an extremely attractive market for investment in pharmaceuticals and the country's enormous potential for exports. He expects sales to bounce back to rates similar to those of 2019 and to grow by between 10 and 15 per cent.
In 2020, sales of Egyptian pharmaceuticals recorded LE125 billion. Some LE90 billion of this was chalked up to the private sector, while the rest, some LE35 billion, was earned by state-owned companies, according to figures released by the cabinet.
President Abdel-Fattah Al-Sisi also inaugurated the first city dedicated to manufacturing medicines in Egypt and the Middle East on 180,000 square metres of land earlier this month, underlining Egypt's goal of acquiring further industrial and technological capacity in the pharmaceuticals industry and to attract further international investment.
The new pharmaceuticals city will work according to the highest quality standards in order to guarantee the acquisition of the quality certificates that will make it easier for Egyptian products to access foreign markets.
In his comments to Al-Ahram Weekly, Al-Ezaby stressed there was a difference between manufacturing finished pharmaceuticals and producing raw ingredients known as active pharmaceutical ingredients (APIs). The latter can require more meticulous work and larger investments, he said. Egypt has begun producing APIs at the Nasr Company for Pharmaceutical Chemicals.
However, the country faces formidable competition from the mass production policies of India and China, diminishing the Nasr Company's ability to compete internationally, Al-Ezaby said.
Even so, the coronavirus pandemic has underlined the need for at least a portion of APIs to be locally manufactured, with the wisdom of depending solely on importing APIs, with the possibility of disruption in supplies, being questioned. Al-Ezaby said that factories manufacturing APIs should be set up in Egypt, as global developments and currency fluctuations could affect imports of raw materials.
"Egypt's pharmaceutical sector is conducting serious studies on the establishment of factories to produce APIs. A group of investors is studying market needs, the number of factories that could be built, and the investments expected to be pumped in," he said, expecting that the studies would be concluded by the end of the year and the factories constructed within two-and-a-half years.
He said that this did not mean that the country would necessarily be able to produce a full range of pharmaceutical products or all the APIs it needs. However, it would mean that it would be able to become self-sufficient in necessary drugs, such as those used to treat diabetes and hypertension and certain antibiotics, Al-Ezaby said.
Investment in Egypt's pharmaceutical sector has reached LE300 billion, he added, saying that 90 per cent of this has been in the private sector and the rest in state-owned facilities. Foreign investment has comprised 20 per cent of the total, with the remaining 80 per cent being Egyptian.
"These indicators render the Egyptian pharmaceutical sector extremely attractive to investment. The country's population is huge, crossing the 100 million mark, and every year more than two million more babies are born," Al-Ezaby said.
There are 152 pharmaceutical factories operating in Egypt, of which eight are state-owned and five are owned by foreign companies, he added. "In the next three years, 40 factories — all currently being built — will access the Egyptian market."
The Egyptian pharmaceutical sector is trying to shift from manufacturing traditional drugs to more complex and more profitable ones including ones that use advanced biotechnology to access foreign markets, Al-Ezaby said.
Large pharmaceutical companies have begun to set up smaller concerns to produce traditional medicines so that they can devote themselves to the manufacture of higher-priced and more profitable drugs.
Egypt currently produces 88 per cent of its needs for pharmaceuticals and imports 12 per cent. It is entering a new phase after the cabinet approved a new law regulating medical research at the end of 2020.
"The sector is targeting the medical industries, which require mega-investments in biotechnology production lines," Al-Ezaby stated.
Drug prices in Egypt have been almost stagnant over the past two decades, he said, but over the last few years prices have been increased by the Egyptian Drugs Authority to maintain a balance between the costs of production and the final prices of products.
Increasing the prices of medicines is one of the factors that could increase the value of pharmaceutical exports, today estimated at less than $350 million, Al-Ezaby said. But "Egypt has the potential to export drugs worth more $5 billion annually to East Africa, the Arab world, Eastern Europe, and the Central Asian countries."
He said that Egypt's Universal Health Insurance System would increase investment in the sector since the state supports private-sector hospitals and pharmacies in the scheme. Citizens currently shoulder 80 per cent of the cost of medicines, while the state pays 20 per cent. Under the new system, the government will pay 80 per cent and the citizen 20 per cent, Al-Ezaby said.
The Universal Health Insurance system is scheduled to cover the whole country by 2030.
Egypt first began to export medicines as a result of steps taken by economist and industrialist Talaat Harb in 1939. Until the late 1970s, many medicines available in pharmacies were composed by the pharmacist according to standard recipes that explained the way to manufacture a drug and its side effects, Al-Ezaby said.
Until the 1960s, Egypt also had high-calibre technical facilities, but these lost their competitive edge when they were absorbed by the Ministry of Health. Things have been looking brighter over the past five years, Al-Ezaby commented.
The sector began to improve in the late 1990s when private-sector companies pumped in new investments, in addition to those poured in by state-owned companies EIPICO and Pharco, he explained.
Al-Ezaby said he was hopeful about procedures adopted over the past three years, including measures to eliminate counterfeit drugs, estimated at less than one per cent of the market.

*A version of this article appears in print in the 22 April, 2021 edition of Al-Ahram Weekly


Clic here to read the story from its source.